Endoscopic endonasal management of papillary and adamantinomatous craniopharyngiomas: a comparative operative video with a proposed role for intraoperative Raman spectroscopy
4 affiliations
- 1Division of Neurosurgery, Centre Hospitalier de L’Université de Montréal (CHUM), Québec
- 2Lumedlab, Polytechnique Montréal
- 3Centre de recherche du CHUM (CRCHUM), Montréal; and
- 4Division of Otolaryngology–Head and Neck Surgery, Centre Hospitalier de L’Université de Montréal (CHUM), Québec, Canada
Abstract
Craniopharyngiomas comprise two molecularly distinct subtypes: papillary craniopharyngioma (PCP), driven by BRAF V600E mutations, typically presenting as solid, well-circumscribed third ventricular masses in adults; and adamantinomatous craniopharyngioma (ACP), driven by CTNNB1 mutations, featuring cystic-solid architecture with calcifications and hypothalamic adherences. Two representative cases illustrate their radiological and intraoperative differences via the extended endoscopic endonasal approach. Subtype identification through MRI, intraoperative frozen-section analysis, and CSF liquid biopsy is critical, as it directly shapes surgical strategy and postoperative decisions, including BRAF/MEK inhibitor therapy for PCP. Raman spectroscopy holds promise as a future real-time intraoperative discrimination tool.
The video can be found here: https://stream.cadmore.media/r10.3171/2026.7.FOCVID26127
Related
- Subpial dissection technique in endoscopic endonasal surgery for craniopharyngiomas with supradiaphragmatic extension
- Intraoperative Breakage and Endoscopic Retrieval of a Dismantled Triprong Forceps During Ureterorenoscopic Lithotripsy: A Rare Complication and Review of the Literature
- Association of intraoperative mitoxantrone hydrochloride injection with incidental parathyroidectomy and parathyroid autotransplantation during gasless unilateral axillary endoscopic thyroidectomy: a propensity score-matched retrospective cohort study
- Endoscopic Excision of a C5 Osteoid Osteoma With Intraoperative Computed Tomography
- EUS-guided targeted epinephrine injection and immediate intraoperative bleeding during endoscopic mucosal resection: a retrospective cohort study (with video)
BibTeX
@article{jemel2026endoscopic,
title = {{Endoscopic endonasal management of papillary and adamantinomatous craniopharyngiomas: a comparative operative video with a proposed role for intraoperative Raman spectroscopy}},
author = {Nesrine Jemel and Ana Bokasova and Najib Nassiri and Philippe Lavigne and Frederic Leblond and Moujahed Labidi},
journal = {Neurosurgical Focus: Video},
year = {2026},
month = oct,
doi = {10.3171/2026.7.focvid26127},
url = {https://doi.org/10.3171/2026.7.focvid26127},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - Endoscopic endonasal management of papillary and adamantinomatous craniopharyngiomas: a comparative operative video with a proposed role for intraoperative Raman spectroscopy
AU - Nesrine Jemel
AU - Ana Bokasova
AU - Najib Nassiri
AU - Philippe Lavigne
AU - Frederic Leblond
AU - Moujahed Labidi
PY - 2026
DA - 2026/10/01
JO - Neurosurgical Focus: Video
DO - 10.3171/2026.7.focvid26127
UR - https://doi.org/10.3171/2026.7.focvid26127
AB - Craniopharyngiomas comprise two molecularly distinct subtypes: papillary craniopharyngioma (PCP), driven by BRAF V600E mutations, typically presenting as solid, well-circumscribed third ventricular masses in adults; and adamantinomatous craniopharyngioma (ACP), driven by CTNNB1 mutations, featuring cystic-solid architecture with calcifications and hypothalamic adherences. Two representative cases illustrate their radiological and intraoperative differences via the extended endoscopic endonasal approach. Subtype identification through MRI, intraoperative frozen-section analysis, and CSF liquid biopsy is critical, as it directly shapes surgical strategy and postoperative decisions, including BRAF/MEK inhibitor therapy for PCP. Raman spectroscopy holds promise as a future real-time intraoperative discrimination tool. The video can be found here: https://stream.cadmore.media/r10.3171/2026.7.FOCVID26127
SN - 2643-5217
ER -